Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function
Philipp Renner(Robert Bosch Hospital), M.H. Dahlke(University of Regensburg), Pompiliu Piso(Krankenhaus Barmherzige Brüder), Felix Popp(University of Regensburg), Edward K. Geissler(University Hospital Regensburg), Hans J. Schlitt(University Hospital Regensburg), Andreas Rosenauer(University of Bremen), Elke Eggenhofer(University Hospital Regensburg), Przemyslaw Slowik(University of Regensburg), Jonas Steinmann(University of Regensburg)
Cited by 124
Related Papers
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
|Annals of Surgery|2012|1.3k
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
|Frontiers in Immunology|2012|820
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
|Transplantation|2015|417